READ MORE
READ MORE
Further to our update of 17 August 2022, one manufacturer of equine influenza vaccination doses, Boehringer Ingelheim, has identified problems with the distribution of its product, Proteq. The company has advised that this issue is likely to persist until the end of October, with no further stock able to be supplied before this time. The BHA is working closely with the British Equine Veterinary Association (BEVA) and our colleagues in other equestrian sports to establish the full extent of the c